Owen Hughes insider trades
Open-market stock purchases and sales by Owen Hughes, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Jun 5, 2014.
Track record: 88% of 8 scored buys are up 5% or more since purchase, averaging +106%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| May 11, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| Mar 16, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| Mar 16, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| Dec 4, 2025 | XOMA XOMA Royalty Corp | Bought | $2.5M |
Companies traded
- CCCC C4 Therapeutics, Inc: other filings, last Jun 24, 2026
- ANAB Anaptysbio, Inc: other filings, last May 11, 2026
- XOMA XOMA Royalty Corp: 7 buys, 2 sales, last Apr 20, 2026
- IKNA Ikena Oncology, Inc: other filings, last Jun 7, 2024
- RDUS Radius Health, Inc: 2 sales, last Aug 15, 2022
- PRDS Pardes Biosciences, Inc: other filings, last Dec 23, 2021
- TBIO Translate Bio, Inc: 4 sales, last Sep 14, 2021
- CGEM Cullinan Management, Inc: 1 buy, last Jan 12, 2021